glp 1 agonist structure Peptide sequences and molecular structures of FDA approved GLP-1 RAs Emerging Trends in the Development

Issue 42 of The Altascientist explores GLP-1 receptor agonist drug development, covering preclinical models, bioanalytical assays, clinical study design, and manufacturing

bimagrumab) may improve the body composition during WL and are in early phase clinical trials

Ozempic alternatives in the GLP-1 family offer effective weight loss pathways

Obesity is a complex disease characterized by excessive fat accumulation which is caused by genetic, environmental and other factors

Find out everything about this - if its true and worth all the hype.

A newly published clinical investigation in the British Journal of Anaesthesia (May 2025 issue) reveals compelling evidence linking glucagon-like peptide-1 receptor agonists (GLP-1RAs) to impaired gastric emptying (IGE)